General Information of Drug Transporter (DT)
DT ID DTD0256 Transporter Info
Gene Name SLC2A14
Transporter Name Glucose transporter type 14
Gene ID
144195
UniProt ID
Q8TDB8
Post-Translational Modification of This DT
Overview of SLC2A14 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

67

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC2A14 Asparagine 67 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

140

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Serine 140 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A14 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Serine 260 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A14 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

270

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Serine 270 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC2A14 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

274

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Serine 274 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC2A14 [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

499

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Serine 499 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC2A14 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

509

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Serine 509 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [4] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

256

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Threonine 256 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A14 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

516

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Threonine 516 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A14 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

517

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Threonine 517 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC2A14 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

518

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC2A14 Threonine 518 has the potential to affect its expression or activity.

Ubiquitination

  Asparticacid

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [11]

Role of PTM

Potential impacts

Modified Residue

Asparticacid

Modified Location

268

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Asparticacid 268 has the potential to affect its expression or activity.

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [12]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

158

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Cystine 158 has the potential to affect its expression or activity.

  Glutamicacid

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [11]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

168

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Glutamicacid 168 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A14 [7] , [12]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

244

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Glutamicacid 244 has the potential to affect its expression or activity.

  Glutamine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [11]

Role of PTM

Potential impacts

Modified Residue

Glutamine

Modified Location

278

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Glutamine 278 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A14 [7] , [11]

Role of PTM

Potential impacts

Modified Residue

Glutamine

Modified Location

292

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Glutamine 292 has the potential to affect its expression or activity.

  Glycine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [13]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

491

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Glycine 491 has the potential to affect its expression or activity.

  Leucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [12]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

282

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Leucine 282 has the potential to affect its expression or activity.

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [12]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

267

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Lysine 267 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC2A14 [7] , [11]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

277

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Lysine 277 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC2A14 [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

514

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Lysine 514 has the potential to affect its expression or activity.

  Proline

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [13]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

405

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Proline 405 has the potential to affect its expression or activity.

  Tryptophan

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [7] , [11]

Role of PTM

Potential impacts

Modified Residue

Tryptophan

Modified Location

254

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 Tryptophan 254 has the potential to affect its expression or activity.

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC2A14 [13]

Role of PTM

Potential impacts

Modified Location

529

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC2A14 529 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR14_HUMAN)
2 Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
3 Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
4 Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
5 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
6 System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3.
7 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
8 Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017 Jan 12;129(2):e1-e12.
9 Global Analyses of Selective Insulin Resistance in Hepatocytes Caused by Palmitate Lipotoxicity. Mol Cell Proteomics. 2018 May;17(5):836-849.
10 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
11 Global identification of modular cullin-RING ligase substrates. Cell. 2011 Oct 14;147(2):459-74.
12 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
13 Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.